Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
- December |
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
- 2019 -
2020
-
2021
-
2022
-
2023
-
2024
December 2019 - 48 products
L
IP
Orkambi 75 mg lumacaftor / 94 mg
ivacaftor
56
9524.65
10080.10
10 %
Granulate: 2 Active Agents
Vertex
Pharmaceuticals (CH)
GmbH
A / SL
FB
G
L
IP
Talzenna 0.5 mg
30
2646.97
2895.15
10 %
Capsules: Talazoparibum
Pfizer AG
A / SL
FB
G
IP
CI
Rosuvastatin NOBEL 5 mg
190
PR
PR
k.A.
Coated tablets: Rosuvastatinum 5 mg
NOBEL Pharma Schweiz AG
B
FB
G
IP
Rosuvastatin NOBEL 10 mg
190
PR
PR
k.A.
Coated tablets: Rosuvastatinum 10 mg
NOBEL Pharma Schweiz AG
B
FB
G
IP
Rosuvastatin NOBEL 20 mg
120
PR
PR
k.A.
Coated tablets: Rosuvastatinum 20 mg
NOBEL Pharma Schweiz AG
B
FB
G
IP
Talzenna 0.1 mg
30
PR
PR
k.A.
Capsules: Talazoparibum
Pfizer AG
A
FB
G
IP
Talzenna 0.35 mg
30
PR
PR
k.A.
Capsules: Talazoparibum
Pfizer AG
A
FB
G
L
IP
Bortezomib liquid Spirig HC 3.5
mg/1.4 ml
372.78
421.85
10 %
Injection solution: Bortezomibum 3.5mg / 1.4ml
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
Bortezomib liquid Spirig HC 7
mg/2.8 ml
641.18
713.75
10 %
Injection solution: Bortezomibum 7mg / 2.8ml
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Rosuvastatin NOBEL 5 mg
30
7.12
16.95
10 %
Coated tablets: Rosuvastatinum 5 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
L
IP
CI
Rosuvastatin NOBEL 5 mg
105
24.93
43.40
10 %
Coated tablets: Rosuvastatinum 5 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
L
IP
Rosuvastatin NOBEL 10 mg
30
8.12
18.05
10 %
Coated tablets: Rosuvastatinum 10 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
L
IP
Rosuvastatin NOBEL 10 mg
105
28.43
47.20
10 %
Coated tablets: Rosuvastatinum 10 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
L
IP
Rosuvastatin NOBEL 20 mg
30
11.78
29.20
10 %
Coated tablets: Rosuvastatinum 20 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
L
IP
Rosuvastatin NOBEL 20 mg
105
41.24
61.10
10 %
Coated tablets: Rosuvastatinum 20 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
IP
CI
Temozolomid Accord 5 mg
5
10.45
27.80
10 %
Capsules: Temozolomidum 5 mg
Accord Healthcare AG
A / SL / SG
FB
G
IP
CI
Temozolomid Accord 5 mg
20
38.36
58.15
10 %
Capsules: Temozolomidum 5 mg
Accord Healthcare AG
A / SL / SG
FB
G
IP
Temozolomid Accord 20 mg
5
41.80
61.85
10 %
Capsules: Temozolomidum 20 mg
Accord Healthcare AG
A / SL / SG
FB
G
IP
Temozolomid Accord 20 mg
20
148.23
177.65
10 %
Capsules: Temozolomidum 20 mg
Accord Healthcare AG
A / SL / SG
FB
G
IP
Temozolomid Accord 100 mg
5
177.92
209.90
10 %
Capsules: Temozolomidum 100 mg
Accord Healthcare AG
A / SL / SG
FB
G
IP
Temozolomid Accord 100 mg
20
626.90
698.20
10 %
Capsules: Temozolomidum 100 mg
Accord Healthcare AG
A / SL / SG
FB
G
IP
Temozolomid Accord 140 mg
5
292.63
334.65
10 %
Capsules: Temozolomidum 140 mg
Accord Healthcare AG
A / SL / SG
FB
G
IP
Temozolomid Accord 140 mg
20
1031.11
1137.80
10 %
Capsules: Temozolomidum 140 mg
Accord Healthcare AG
A / SL / SG
FB
G
IP
Temozolomid Accord 180 mg
5
318.96
363.30
10 %
Capsules: Temozolomidum 180 mg
Accord Healthcare AG
A / SL / SG
FB
G
IP
Temozolomid Accord 180 mg
20
1275.85
1404.00
10 %
Capsules: Temozolomidum 180 mg
Accord Healthcare AG
A / SL / SG
FB
G
IP
Temozolomid Accord 250 mg
5
445.02
500.40
10 %
Capsules: Temozolomidum 250 mg
Accord Healthcare AG
A / SL / SG
FB
G
L
IP
CI
Posaconazol Accord 100 mg
24
561.21
626.75
10 %
Gastric juice resistant tablets: Posaconazolum 100 mg
Accord Healthcare AG
B / SL / SG
FB
G
L
IP
CI
Posaconazol Accord 100 mg
96
2244.86
2457.85
10 %
Gastric juice resistant tablets: Posaconazolum 100 mg
Accord Healthcare AG
B / SL / SG
FB
G
L
IP
CI
AJOVY 225 mg
1.5 ml
405.97
457.95
10 %
Injection solution in prefilled syringe: Fremanezumabum 225mg / 1.5ml
Teva Pharma AG
B / SL
FB
G
L
IP
CI
AJOVY 225 mg
3 x 1.5 ml
1217.90
1340.95
10 %
Injection solution in prefilled syringe: Fremanezumabum 225mg / 1.5ml
Teva Pharma AG
B / SL
FB
G
L
IP
CI
Orkambi 100 mg lumacaftor / 125 mg
ivacaftor
56
9524.65
10080.10
10 %
Granulate: 2 Active Agents
Vertex
Pharmaceuticals (CH)
GmbH
A / SL
FB
G
L
IP
Orkambi 150 mg lumacaftor / 188 mg
ivacaftor
56
9524.65
10080.10
10 %
Granulate: 2 Active Agents
Vertex
Pharmaceuticals (CH)
GmbH
A / SL
FB
G
L
IP
MVASI 100 mg/4 ml
257.57
296.55
10 %
Concentrate for infusion: Bevacizumabum 100mg / 4ml
Amgen Switzerland AG
A / SL
FB
G
L
IP
MVASI 400 mg/16 ml
962.84
1063.55
10 %
Concentrate for infusion: Bevacizumabum 400mg / 16ml
Amgen Switzerland AG
A / SL
FB
G
IP
CI
Delstrigo
30
628.50
699.95
10 %
Coated tablets: 3 Active Agents
MSD Merck Sharp &
Dohme AG
A / SL
FB
G
IP
CI
Pifeltro
30
436.06
490.65
10 %
Coated tablets: Doravirinum 100 mg
MSD Merck Sharp &
Dohme AG
A / SL
FB
G
L
IP
CI
Talzenna 0.25 mg
30
1557.04
1709.80
10 %
Capsules: Talazoparibum
Pfizer AG
A / SL
FB
G
L
IP
Talzenna 1 mg
30
4674.98
5100.75
10 %
Capsules: Talazoparibum 1 mg
Pfizer AG
A / SL
FB
G
L
IP
Tremfya 100 mg/1 ml
2098.96
2299.15
10 %
Injektionslösung in einem Fertigpen: Guselkumabum 100 mg/ml
Janssen-Cilag AG
B / SL
FB
G
IP
CI
CM
BETADINA, desinfizierende
Wundsalbe 10 mg/g
30 g
PR
PR
k.A.
Ointment: Iodum 10 mg
iNova Pharmaceuticals
(Switzerland) AG
D
FB
G
IP
CI
CM
BETADINA, desinfizierende
Wundsalbe 10 mg/g
100 g
PR
PR
k.A.
Ointment: Iodum 10 mg
iNova Pharmaceuticals
(Switzerland) AG
D
FB
G
IP
Rosuvastatin NOBEL 40 mg
30
PR
PR
k.A.
Coated tablets: Rosuvastatinum 40 mg
NOBEL Pharma Schweiz AG
B
FB
G
IP
Rosuvastatin NOBEL 40 mg
105
PR
PR
k.A.
Coated tablets: Rosuvastatinum 40 mg
NOBEL Pharma Schweiz AG
B
FB
G
IP
Mylotarg 5 mg
PR
PR
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Gemtuzumabum Ozogamicinum 5 mg
Pfizer AG
A
FB
G
CI
A
Infludo
20 ml
PR
PR
k.A.
Tropfen zum Einnehmen: 6 Active Agents
Weleda AG
D
FB
G
CI
A
Infludo
50 ml
PR
PR
k.A.
Tropfen zum Einnehmen: 6 Active Agents
Weleda AG
D
FB
G
IP
CI
CM
BETADINA
30 ml
PR
PR
k.A.
desinfizierende Lösung: Iodum 11 mg/ml
iNova Pharmaceuticals
(Switzerland) AG
D
FB
G
IP
CI
CM
BETADINA
120 ml
PR
PR
k.A.
desinfizierende Lösung: Iodum 11 mg/ml
iNova Pharmaceuticals
(Switzerland) AG
D
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
